Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation containing TLR agonist and methods of use

Formulation containing TLR agonist and methods of use

US Patent 12440559 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Single vial vaccine formulations2025
Formulation containing TLR agonist and methods of use2025
Nanoalum particles containing a pegylated lipid sizing agent2025
Composition and method for spray drying an adjuvant vaccine emulsion2025
Pegylated liposomes and methods of use2025
Solanesol vaccine adjuvants and methods of preparing same2025
Nanostructured lipid carriers and stable emulsions and uses thereof2025
Single vial vaccine formulations2023
Adjuvant formulations comprising TLR4 agonists and methods of using the same2022
Formulation containing TLR agonist and methods of use2022
PEGylated liposomes and methods of use2022
Nanoalum particles comprising a PAA sizing agent2021